Good research as usual.
This campaign supports PIQ's case in pursuing a reimbursement code in the US. If successful PromarkerD becomes a screening test for early intervention. PIQ has been at it since November it would be good to know how long the process takes.
And if Janssen's drug effectiveness can measured PromarkerD becomes a monitoring test.
Waiting for news........
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $58.92M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.0¢ | $42.78K | 116.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1408 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 111109 | 2 |
View Market Depth
| Last trade - 13.47pm 31/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |